Challenges to Achieving Value in Drug Spending in a Decentralized Country: The Spanish Case
Open Access
- 1 July 2003
- journal article
- website
- Published by Elsevier in Value in Health
- Vol. 6 (s1) , S52-S63
- https://doi.org/10.1046/j.1524-4733.6.s1.6.x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Public Demand for Medicines, Price Regulation, and Government — Industry Relationships in SpainEnvironment and Planning C: Government and Policy, 2001
- Pharmaceutical Expenditure in Spain: Cost and ControlInternational Journal of Health Services, 2000
- A comparative analysis of generics markets in five European countriesHealth Policy, 2000